ZDHHC1 pseudogene 1 (ZDHHC1P1)

ZDHHC1 pseudogene 1 (ZDHHC1P1) is annotated as a pseudogene in the human genome. Pseudogenes are DNA sequences resembling known genes but have typically lost the ability to encode functional proteins due to mutations, deletions, or loss of regulatory elements. ZDHHC1P1 shares sequence homology with the protein-coding gene ZDHHC1 (Zinc Finger DHHC-Type Containing 1), which is a palmitoyltransferase involved in immune response and tumor suppression[1][2][3]. However, ZDHHC1P1 itself does not encode a functional protein and is not documented to have biological activity, molecular interactions, or disease relevance. No drugs are known to target ZDHHC1P1, and it is not used as a biomarker for disease monitoring or patient stratification. There is no evidence that ZDHHC1P1 plays a role in disease mechanisms, nor is it associated with safety concerns in therapeutic contexts. ZDHHC1P1 should not be confused with the functional gene ZDHHC1[6]. Is there something wrong with this target? Yes: ZDHHC1P1 is a pseudogene, not an established therapeutic target. There is no data supporting its role in signaling, disease, or pharmacology. Any purported biological function or disease association for ZDHHC1P1 would likely be a result of mistaken identity with its parental functional gene ZDHHC1[6]. If the intent was to identify a target relevant for therapy or drug discovery, ZDHHC1P1 is not suitable. Summary: ZDHHC1P1 is a non-functional pseudogene, not considered a molecular target for drugs, biomarkers, or therapeutic development. No biological, disease, or clinical relevance has been documented for this entity[6].

Other names

ZDHHC1P1ZDHHC1 pseudogene 1